Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

(Reuters) -Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much ...

The Centers for Disease Control and Prevention May 8 released an analysis that found declines in hospitalizations for infants infected with respiratory syncytial virus during the 2024-2025 RSV season.

In 2023, U.S. health officials began recommending two new measures to prevent the toll on infants -- one was a lab-made ...

There was a significant drop in the number of babies hospitalized with RSV this year; a positive news story that can be ...

A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged 60 and older, with approximately 75% effectiveness against RSV-associated ...

His CDC bio touts his experience as an attorney, including as a federal prosecutor. The scientific panel's recommendations on Wednesday were: — People 50 to 59 should be able to get vaccinated against ...

According to the CDC, RSV is the leading cause of infant hospitalization ... reduces the likelihood of experiencing severe symptoms. With cases spreading at rates higher than ever before, RSV ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Recommendations supporting respiratory syncytial virus vaccines marketed by Pfizer (NYSE:PFE) and GSK (NYSE:GSK) made last ...